Active Ingredients
Rosmarinus Officinalis (Rosemary) Leaf Oil (0.1%), Cymbopogon Nardus (Citronella) Oil (0.1%).
Rosmarinus Officinalis (Rosemary) Leaf Oil (0.1%), Cymbopogon Nardus (Citronella) Oil (0.1%).
Topical or surface spray to protect against lice.
Water/Aqua/Eau, SD Alcohol 40-B (Alcohol Denat.), PEG-40 Hydrogenated Castor Oil, Trideceth-9, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Eucalyptus Globulus Leaf Oil, Aloe Barbadensis Leaf Juice, Panthenol, Hydrolyzed Wheat Protein, Fragrance (Parfum), Cocamidopropyl Betaine, Triethyl Citrate.
Apply Spray daily to entire surface, or hair (wet or dry), to protect against lice, nits and other insect infestation.
Flammable.
Do not use near open flame or while smoking. Avoid spraying in eyes.
Keep out of the reach of children.
Use only as directed.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57240-2041-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-edd7-cd31-e053-dbdaa90ab51a | Zippity Doo's™ SHIELD SPRAY |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57240-2041-1 | Zippity Doos SHIELD | 249 mL in 1 BOTTLE | LIQUID | 249 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57240-2041 | ZIPPITY DOOS SHIELD (ROSEMARY) LIQUID [LAURUS ENTERPRISES, LLC] | 1 | Legacy NDC, 1 package rows | 20130402_e47df67d-61f0-472e-8dfb-f19f1baf21a7.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Rosemary | ACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| Rosemary | ACTIVE MOIETY | IJ67X351P9 | 1 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| Citronella Oil | INACTIVE INGREDIENT | QYO8Q067D0 | 1 | |
| Cocamidopropyl Betaine | INACTIVE INGREDIENT | 5OCF3O11KX | 1 | |
| Eucalyptus Oil | INACTIVE INGREDIENT | 2R04ONI662 | 1 | |
| Hamamelis Virginiana Top Water | INACTIVE INGREDIENT | NT00Y05A2V | 1 | |
| Hydrogenated Castor Oil | INACTIVE INGREDIENT | ZF94AP8MEY | 1 | |
| Oxybenzone | INACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| PEG/PPG-17/18 Dimethicone | INACTIVE INGREDIENT | 2E4ZJH3Z6R | 1 | |
| Tea Tree Oil | INACTIVE INGREDIENT | VIF565UC2G | 1 | |
| Triethyl Citrate | INACTIVE INGREDIENT | 8Z96QXD6UM | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57240-2041 | 57240-2041-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Rosemary | IJ67X351P9 | ACTIB |
| Water | 059QF0KO0R | IACT |
| Hydrogenated Castor Oil | ZF94AP8MEY | IACT |
| Tea Tree Oil | VIF565UC2G | IACT |
| Citronella Oil | QYO8Q067D0 | IACT |
| Eucalyptus Oil | 2R04ONI662 | IACT |
| Hamamelis Virginiana Top Water | NT00Y05A2V | IACT |
| Aloe Vera Leaf | ZY81Z83H0X | IACT |
| Panthenol | WV9CM0O67Z | IACT |
| Oxybenzone | 95OOS7VE0Y | IACT |
| Cocamidopropyl Betaine | 5OCF3O11KX | IACT |
| Triethyl Citrate | 8Z96QXD6UM | IACT |
| PEG/PPG-17/18 Dimethicone | 2E4ZJH3Z6R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, EXTENDED RELEASE / ORAL | 393 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED PELLETS / ORAL | 147 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED / ORAL | 7 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 10 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, CHEWABLE / ORAL | 34 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET / SUBLINGUAL | 1.6 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, FOR SUSPENSION / ORAL | 17 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, FILM COATED / ORAL | 3 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET / ORAL | 232 mg | ||
| Eucalyptus Oil | EUCALYPTUS OIL | 2R04ONI662 | SYRUP / ORAL | NA | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, EXTENDED RELEASE / ORAL | 160 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET / ORAL | 52 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, FILM COATED / ORAL | 17 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, EXTENDED RELEASE / ORAL | 129 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, DELAYED RELEASE / ORAL | 1337 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE / ORAL | 405 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 100 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 7 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | SUSPENSION / TOPICAL | 286 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | LIQUID / TOPICAL | 0.24 %w/w | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 147 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, ORALLY DISINTEGRATING / ORAL | 17 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | SUSPENSION, EXTENDED RELEASE / ORAL | 5 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, DELAYED RELEASE / ORAL | 120 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE, DELAYED RELEASE / ORAL | 3.1 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | GRANULE, FOR SUSPENSION / ORAL | 64 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, DELAYED RELEASE / ORAL | 70 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE / ORAL | 10 mg | ||
| Triethyl Citrate | TRIETHYL CITRATE | 8Z96QXD6UM | SUSPENSION / ORAL | 71 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE, EXTENDED RELEASE / ORAL | 410.82 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 394d0c56-a4b2-4acd-8977-ef591a007405 | e47df67d-61f0-472e-8dfb-f19f1baf21a7 | 2013-03-04 | Warnings | 394d0c56-a4b2-4acd-8977-ef591a007405 e47df67d-61f0-472e-8dfb-f19f1baf21a7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.